Welcome to our dedicated page for Jupiter Wellness news (Ticker: jupw), a resource for investors and traders seeking the latest updates and insights on Jupiter Wellness stock.
Jupiter Wellness, Inc. (symbol: JUPW) is a pioneering company in the consumer product development sector, focusing on hemp-derived cannabidiol (CBD) solutions. Founded in 2018 and headquartered in Jupiter, Florida, the company aims to harness the therapeutic potential of CBD to address various medical conditions and ailments including cancer, arthritis, anxiety, insomnia, psoriasis, and chronic pain.
Jupiter Wellness markets CBD-infused sun care lotions under the Canisun brand, offering formulations with various sun protection factors. Additionally, the company is expanding its product range with CBD-infused skincare products under the Caniskin brand and advanced dermatological treatments under the CanidermRx brand.
By integrating CBD's therapeutic properties into everyday wellness products, Jupiter Wellness is at the forefront of a rapidly growing industry. The company continues to achieve significant milestones, driven by ongoing research and development, strategic partnerships, and a commitment to providing innovative solutions for health and wellness.
For further information, Jupiter Wellness can be contacted at:
- Phone: 561-244-7100
- Email: info@JupiterWellness.com
Jupiter Wellness (NASDAQ:JUPW) reported a shareholder letter emphasizing a successful year start with record revenues. CEO Brian John highlighted the renewal of focus on science-backed product development, following a year of patent protection and clinical testing of core products. Key agreements include a licensing deal with Taisho, a major player in the minoxidil market. Additionally, the company is prioritizing upcoming launches of eczema and sexual wellness products. Investors can read the full letter on the company's website.
Jupiter Wellness (NASDAQ:JUPW) has announced the appointment of Dr. Skender Fani to its board of directors, effective September 15, 2022. He replaces Dr. Hector Alila, who will join the Scientific Advisory Board. Dr. Fani brings 40 years of expertise in corporate and sports law, previously advising top European soccer clubs and serving on the boards of various Nasdaq companies. He emphasizes the opportunity to enhance shareholder value and expand the company's reach in health products. Jupiter Wellness focuses on over-the-counter health products, addressing various conditions and generating revenue through sales and licensing.
Jupiter Wellness (Nasdaq:JUPW) announced its participation in Surf Expo from September 8-10, 2022, in Orlando, Florida. The company will showcase its patented sun care product, NoStingz, a sunscreen designed to prevent jellyfish and sea lice stings. CEO Brian John emphasized the product's superiority to major brands, particularly for coastal areas. Surf Expo is a leading trade show for watersport and beach lifestyle products, featuring a wide array of brands and events. Jupiter Wellness focuses on developing health-related OTC products.
Jupiter Wellness (NASDAQ:JUPW) announced a multi-year global licensing agreement through its SRM Entertainment division with Zoonicorn, a preschool animated brand. The agreement allows SRM to develop a line of Sip With Me children's cups featuring Zoonicorn, set to launch in Spring 2023. The property recently debuted its CGI series across multiple streaming platforms, including Peacock and Kidoodle. The Zoonicorn brand aims to impart social-emotional skills to children through engaging adventures.
Jupiter Wellness (NASDAQ:JUPW) reported financial results for Q2 2022, achieving $3,000,582 in revenues, a significant increase from $595,088 in Q2 2021. The company also highlighted the licensing of its SULT1A1 minoxidil booster to Taisho Pharmaceutical for Japan. Operating expenses decreased to $1,945,999 from $4,332,249 a year earlier, leading to a reduced net loss of $1,440,856 compared to $4,151,074 in the prior year. CEO Brian John expressed confidence in the company's momentum and roadmap for 2022.
Jupiter Wellness (NASDAQ:JUPW) announced a multi-year licensing agreement with LAFIG Belgium to feature the Smurfs brand on its Sip With Me children's hydration products. The collaboration aims to launch a line of Smurf-themed products, including patented double drinking straw tumblers, expected in retail by July 2023. This initiative enhances SRM's commitment to expanding licensing partnerships, coinciding with the upcoming Smurfs film set for 2024, aiming to inspire children with innovative drinkware.
Jupiter Wellness (Nasdaq:JUPW) announced a Forbearance and Settlement Agreement with Benuvia (formerly Next Frontier Pharmaceuticals) involving a $3 million payment and capital stock representing 8.0% of Benuvia's SPAC merger with Pono Capital Corp. The agreement stipulates a repayment plan of three $1 million installments over three months. Funds will be held in escrow until further negotiations with senior lenders conclude. The merger is set to close in Q4 2022, potentially giving Benuvia a pro forma value of $440 million, with expected gross proceeds of $115 million.
Jupiter Wellness (NASDAQ:JUPW) announced plans to develop a new women's sexual wellness product, covered by two issued patents, US #10,357,452 and US #10,064,816. The product, RJ-101, is designed to enhance nipple sensitivity and sexual arousal for both pre- and post-menopausal women. Jupiter Wellness has licensed these patents from Rejoy, Inc., gaining a robust intellectual property position. Clinical trials have demonstrated its efficacy for various conditions, including female orgasmic disorder. The company aims to address significant clinical needs in women's sexual health.
Jupiter Wellness (NASDAQ:JUPW) is advancing RJ-101, a new topical treatment designed to enhance women's sexual wellness. The product, underpinned by two patents, targets nipple-areola sensitivity by contracting smooth muscles, which could improve sexual responses in both pre- and post-menopausal women. Acquired from Applied Biology, it boasts a strong intellectual property portfolio. The treatment aims to address various conditions, including female orgasmic disorder and complications following breast surgery.
Jupiter Wellness (NASDAQ:JUPW) has entered an agreement with Cosmofix Technology and Sanpellegrino Cosmetics for the production and distribution of its minoxidil-based products in 31 countries in Asia and the Middle East. The company will receive an upfront payment and royalties of 10-12% on sales, alongside guaranteed minimum royalty payments. The portfolio includes MinoxiBoost, MinoxiClean, and Photocil, aiming to tap into a market projected at $1.2 billion for minoxidil by 2024, while enhancing access to self-care treatments for skin conditions.
FAQ
What is the market cap of Jupiter Wellness (jupw)?
What does Jupiter Wellness, Inc. specialize in?
What are some of the ailments Jupiter Wellness's products aim to treat?
What brands are under Jupiter Wellness, Inc.?
When was Jupiter Wellness, Inc. founded?
Where is Jupiter Wellness, Inc. headquartered?
How can I contact Jupiter Wellness, Inc.?
What is the stock symbol for Jupiter Wellness, Inc.?
Are Jupiter Wellness's products based on CBD?
What is the Canisun brand known for?
What recent achievements has Jupiter Wellness, Inc. made?
